Recommendations for Neonatal Surfactant Therapy

Overview

Journal Paediatr Child Health

Publisher Oxford University Press

Specialty Pediatrics

Date 2009 Aug 12

PMID 19668609

Citations 15

Affiliations

Soon will be listed here.

Citing Articles

Meconium aspiration syndrome: from pathophysiology to treatment.

Dini G, Ceccarelli S, Celi F, Semeraro C, Gorello P, Verrotti A Ann Med Surg (Lond). 2024; 86(4):2023-2031.

PMID: 38576961 PMC: 10990371. DOI: 10.1097/MS9.0000000000001835.

Meconium Aspiration Syndrome: A Narrative Review.

Monfredini C, Cavallin F, Villani P, Paterlini G, Allais B, Trevisanuto D Children (Basel). 2021; 8(3).

PMID: 33802887 PMC: 8002729. DOI: 10.3390/children8030230.

Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?.

Bollag W, Gonzales J Med Hypotheses. 2020; 144:110277.

PMID: 33254581 PMC: 7493731. DOI: 10.1016/j.mehy.2020.110277.

"Optimal surfactant delivery protocol using the bovine lipid extract surfactant: a quality improvement study".

Germain A, Nouraeyan N, Claveau M, Leone M, SantAnna G J Perinatol. 2020; 41(1):17-23.

PMID: 33011749 PMC: 7532933. DOI: 10.1038/s41372-020-00846-1.

Characteristics and outcomes of preterm neonates according to number of doses of surfactant received.

Coshal H, Mukerji A, Lemyre B, Ng E, Alvaro R, Ethier G J Perinatol. 2020; 41(1):39-46.

PMID: 32792633 PMC: 7424238. DOI: 10.1038/s41372-020-00779-9.

References

Halliday H . Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Drugs. 1996; 51(2):226-37. DOI: 10.2165/00003495-199651020-00004. View

Hentschel R, Brune T, Franke N, Harms E, Jorch G . Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants. Intensive Care Med. 2002; 28(5):622-8. DOI: 10.1007/s00134-002-1277-7. View

Merritt T, Strayer D, Hallman M, Spragg R, Wozniak P . Immunologic consequences of exogenous surfactant administration. Semin Perinatol. 1988; 12(3):221-30. View

Long W, CORBET A, Cotton R, Courtney S, McGuiness G, Walter D . A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. N Engl J Med. 1991; 325(24):1696-703. DOI: 10.1056/NEJM199112123252404. View

Soll R, Jacobs J, Pashko S, Thomas R . Cost effectiveness of beractant in the prevention of respiratory distress syndrome. Pharmacoeconomics. 1993; 4(4):278-86. DOI: 10.2165/00019053-199304040-00006. View

Kendig J, Ryan R, Sinkin R, Maniscalco W, Notter R, Guillet R . Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics. 1998; 101(6):1006-12. DOI: 10.1542/peds.101.6.1006. View

Bos A, Tibboel D, Hazebroek F, Molenaar J, Lachmann B, Gommers D . Surfactant replacement therapy in high-risk congenital diaphragmatic hernia. Lancet. 1991; 338(8777):1279. DOI: 10.1016/0140-6736(91)92151-q. View

Crane J, Armson A, Brunner M, de la Ronde S, Farine D, Keenan-Lindsay L . RETIRED: Antenatal corticosteroid therapy for fetal maturation. J Obstet Gynaecol Can. 2003; 25(1):45-52. DOI: 10.1016/s1701-2163(16)31081-7. View

Toti P, Buonocore G, Rinaldi G, Catella A, Bracci R . Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study. Biol Neonate. 1996; 70(1):21-8. DOI: 10.1159/000244343. View

10.

CORBET A, Gerdes J, Long W, Avila E, Puri A, Rosenberg A . Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa. J Pediatr. 1995; 126(6):969-78. DOI: 10.1016/s0022-3476(95)70226-1. View

11.

Findlay R, Taeusch H, Walther F . Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 1996; 97(1):48-52. View

12.

Phibbs C, Phibbs R, Wakeley A, Schlueter M, Sniderman S, TOOLEY W . Cost effects of surfactant therapy for neonatal respiratory distress syndrome. J Pediatr. 1993; 123(6):953-62. DOI: 10.1016/s0022-3476(05)80394-4. View

13.

. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. Survanta Multidose Study Group. J Pediatr. 1994; 124(6):962-7. DOI: 10.1016/s0022-3476(05)83193-2. View

14.

Pandit P, Dunn M, Colucci E . Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 1995; 95(1):32-6. View

15.

Kattwinkel J, Bloom B, Delmore P, Glick C, Brown D, Lopez S . High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics. 2000; 106(2 Pt 1):282-8. DOI: 10.1542/peds.106.2.282. View

16.

Costakos D, Allen D, Krauss A, Ruiz N, Fluhr K, Stouvenel A . Surfactant therapy prior to the interhospital transport of preterm infants. Am J Perinatol. 1996; 13(5):309-16. DOI: 10.1055/s-2007-994348. View

17.

Glick P, Leach C, Besner G, Egan E, Morin F, Robinson L . Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg. 1992; 27(7):866-9. DOI: 10.1016/0022-3468(92)90386-l. View

18.

Thornton C, Halliday H, OHara M . Surfactant replacement therapy in preterm neonates: a comparison of postmortem pulmonary histology in treated and untreated infants. Pediatr Pathol. 1994; 14(6):945-53. DOI: 10.3109/15513819409037691. View

19.

Rodriguez R, Martin R . Exogenous surfactant therapy in newborns. Respir Care Clin N Am. 1999; 5(4):595-616. View

20.

Baraldi E, Pettenazzo A, Filippone M, Magagnin G, Saia O, Zacchello F . Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol. 1993; 15(3):157-62. DOI: 10.1002/ppul.1950150306. View